Point72 Middle East FZE’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
CIP
FLAM
N
Point72 Middle East FZE's ATRC Position: Q1 2024 in Review
Point72 Middle East FZE sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 26,086 shares — an estimated $931K sold.
Point72 Middle East FZE first reported a position in ATRC in Q4 2022 and held it in 4 quarters. The position peaked at $931K in Q4 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.
- Point72 Middle East FZE reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
- Point72 Middle East FZE sold 26,086 AtriCure shares in Q1 2024, an estimated $931K.
- Point72 Middle East FZE first reported a position in AtriCure in Q4 2022 and held it in 4 quarters.
- Point72 Middle East FZE's AtriCure position peaked at $931K in Q4 2023.
- 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.
Based on Point72 Middle East FZE's 13F filing for Q1 2024.